Detalhe da pesquisa
1.
Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells.
Int J Mol Sci
; 23(14)2022 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887063
2.
SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo.
Cancer Cell Int
; 20: 312, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694934
3.
Preparation and Evaluation of Mebendazole Microemulsion for Intranasal Delivery: an Alternative Approach for Glioblastoma Treatment.
AAPS PharmSciTech
; 21(7): 264, 2020 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32980937
4.
Mifepristone improves chemo-radiation response in glioblastoma xenografts.
Cancer Cell Int
; 13(1): 29, 2013 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23530939
5.
Near-Infrared Fluorescence Imaging in Preclinical Models of Glioblastoma.
J Imaging
; 9(10)2023 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37888319
6.
Pharmacokinetics and Anti-Tumor Efficacy of PEGylated Liposomes Co-Loaded with Cisplatin and Mifepristone.
Pharmaceuticals (Basel)
; 16(10)2023 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37895808
7.
The Therapeutic Potential of Chemo/Thermotherapy with Magnetoliposomes for Cancer Treatment.
Pharmaceutics
; 14(11)2022 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36432634
8.
Mifepristone Repurposing in Treatment of High-Grade Gliomas.
Front Oncol
; 11: 606907, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33680961
9.
Corrigendum: Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide.
Front Oncol
; 11: 675806, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828996
10.
Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide.
Front Oncol
; 10: 581814, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123485
11.
Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma.
Cancers (Basel)
; 11(1)2018 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30583528